Loading organizations...

§ Venture Capital · San Francisco, CA, USA
Boutique venture capital firm investing in growth-stage technology, life sciences, healthcare, space, and frontier tech companies.
Green Sands Equity is a boutique venture capital and investment firm, headquartered in San Francisco with a significant global footprint including offices in Tokyo, Doha, Zurich, Singapore, Dubai, and New York. The firm was notably ranked among the top 5 investors in the U.S. by Fortune Magazine in 2022, a testament to its impactful strategy. Its impressive portfolio features renowned companies such as Spotify, SpaceX, Airbnb, Pasqal, and Colossal. Green Sands Equity focuses on growth and late-stage investments across critical sectors including technology, life sciences, healthcare, space, and frontier technology, often co-investing with major institutions. Chairman and CEO Reema Khan, who also serves as a trustee of the SETI Institute and a UN ambassador for Women in Science & Technology, co-founded the firm in 2016 with Omar Farooqui.
# Green Sands Equity
Green Sands Equity (GSE) is a boutique private equity investment and corporate finance advisory firm with a global footprint, headquartered in San Francisco and operating out of Dubai, Frankfurt, Singapore, and Zurich. The firm specializes in Growth Capital, Investment Advisory, and Strategic Buyouts, focusing on technology, healthcare, space, and frontier tech sectors. GSE’s mission is to back visionary leaders and innovative companies that drive human progress and economic growth, particularly in emerging markets. Their investment philosophy blends pragmatic innovation with a long-term outlook, balancing shorter-term returns (3–5 years) with strategic, impact-driven bets. By supporting companies at the intersection of data, hardware, and software—especially those with enterprise applications—Green Sands Equity plays a catalytic role in shaping the next generation of transformative startups and scaling businesses globally.
Founded in 2015, Green Sands Equity was established by Reema Khan, who serves as the firm’s founder and CEO. Khan’s background in technology, healthcare, and global policy strategy has shaped GSE’s unique approach to investing. The firm began as a boutique venture capital and advisory practice, quickly expanding its reach across North America, Europe, the Middle East, and Asia. Over the years, Green Sands Equity has evolved from a regional player to a globally recognized name, known for its hands-on advisory services and strategic co-investments alongside leading institutional investors. The firm’s early focus on technology and healthcare has broadened to include frontier tech, space, and policy-driven innovation, reflecting both market trends and Khan’s vision for responsible, high-impact investing.
Green Sands Equity is riding the wave of digital transformation, healthcare innovation, and the rise of frontier technologies. The firm’s focus on data, hardware, and enterprise software aligns with the growing demand for scalable, impactful solutions in an increasingly connected world. By investing in companies that push the boundaries of AI, quantum computing, genomics, and neurotechnology, GSE is helping to accelerate the adoption of technologies that will redefine industries and improve lives. The firm’s global network and policy expertise position it as a bridge between innovators, investors, and policymakers, fostering an ecosystem where breakthrough ideas can thrive. As emerging markets become more central to global innovation, GSE’s local-global model is well-suited to capture new opportunities and drive inclusive growth.
Green Sands Equity is poised to continue shaping the future of technology and healthcare investing, with a growing emphasis on frontier tech and global impact. As the lines between sectors blur and the pace of innovation accelerates, GSE’s ability to combine capital, strategic advisory, and policy insight will be a key advantage. The firm is likely to expand its footprint in emerging markets and deepen its involvement in policy-driven innovation, helping to unlock new sources of growth and investment. In the coming years, Green Sands Equity’s influence will extend beyond its portfolio, as it helps to define the standards for responsible, high-impact investing in a rapidly changing world. From its roots as a boutique advisory firm to its current role as a global catalyst for innovation, Green Sands Equity remains a compelling example of how vision, pragmatism, and global perspective can drive lasting change.
Green Sands Equity has 2 tracked investments across 2 companies. The latest tracked deal is $15.0M Series A in Elve in February 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2024 | Elve | $15.0M Series A | — | Flex Capital, Lockheed Martin Ventures, Paladin Capital Group, Anne Wojcicki, Cambium Capital, Thomas VON Koch, YU Galaxy |
| Aug 1, 2020 | ReViral | $44.0M Series C | Jason Zhou | Andera Partners, OrbiMed, Seroba Life Sciences, Heather Preston, Brace Pharma Capital, NEW Leaf Venture Partners, Novo Holdings, Perceptive Advisors |